A randomized, open-label, comparative evaluation of conversion from calcineurin inhibitors to sirolimus versus continued use of calcineurin inhibitors in renal allograft recipients
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2014
At a glance
- Drugs Sirolimus (Primary) ; Ciclosporin; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms CONVERT
- Sponsors Wyeth
- 10 Apr 2014 Data cleaning project 4: Calcineurin inhibitors deleted from descriptors.
- 18 May 2010 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 18 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History